Efflux Limits Tumor Drug Delivery Despite Disrupted BBB

Apparent blood–brain barrier (BBB) disruption is common in glioblastoma (GBM), but has not translated to improved drug delivery efficacy. Recently, de Gooijer et al. demonstrated that efflux transporters can have a prominent role in limiting drug delivery. These transport systems contribute to ineff...

Full description

Saved in:
Bibliographic Details
Published inTrends in pharmacological sciences (Regular ed.) Vol. 42; no. 6; pp. 426 - 428
Main Authors Griffith, Jessica I., Sarkaria, Jann N., Elmquist, William F.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.06.2021
Online AccessGet full text

Cover

More Information
Summary:Apparent blood–brain barrier (BBB) disruption is common in glioblastoma (GBM), but has not translated to improved drug delivery efficacy. Recently, de Gooijer et al. demonstrated that efflux transporters can have a prominent role in limiting drug delivery. These transport systems contribute to ineffective drug delivery to tumor cells in the brain.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Commentary-1
ISSN:0165-6147
1873-3735
DOI:10.1016/j.tips.2021.03.001